American Regent reported on Thursday the availability of Hydroxyprogesterone Caproate Injection, USP in a 250 mg/ml, 1ml preservative free Single Dose Vial to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.
The company added the US FDA approved Hydroxyprogesterone Caproate Injection, USP is the only preservative free generic alternative to Makena.
In conjunction, Hydroxyprogesterone Caproate Injection, USP can be ordered through wholesalers/distributors within the next several days,said the company.
With a history in generic specialty injectables, the company is engaged in the development, manufacturing and sales of generic and branded IV products.
Fresenius Kabi Introduces Leucovorin Calcium Injection, USP
FDA Approves Dr. Reddy's Tosymra 10 mg, in the US Market
Dr. Reddy's Laboratories Announces the Launch of Propofol Injectable Emulsion, USP in the US Market
Amerigen awarded US FDA's approval for generic mixed amphetamine salts, extended-release capsules
Pharmaceutics International names new president and CEO
Amneal wins US FDA approval for Rivastigmine Transdermal System
Premier Expands Effort to Supply Shortage Generic Drugs
Ferring Pharmaceuticals Adds Two Products to its Reproductive Health Portfolio in the US
China's Bio-Thera Solutions Partners with Cipla to Market Key Cancer Biosimilar
EpicGenetics Moves into New Facility, Expanding Capacity by 4X
Amneal Pharmaceuticals appoints David A. Buchen as SVP, chief legal officer and corporate secretary
Ironwood Pharmaceuticals and Allergan reach agreement to resolve Mylan LINZESS patent litigation
Teva and Amgen Resolve Ongoing Dispute Over Teva's Generic Cinacalet HCl Product